Research Summer School 4 and Networking Conference at NECTAR 2019


Training Workshop: How to find a job after your PhD by Association Bernard Gregory (ABG)
Invited Speakers
James Phillips (UCL) Tissue engineering to repair the nervous system
Ben Newland (Cardiff University) Biomaterial toolbox for studying brain pathology, function and repair
Eilís Dowd (NUIG) Cellular brain repair for Parkinson’s Disease: Is the answer in the (biomaterial) matrix?
Erin Lavik (UMBC) Biomaterials for modelling and repairing the CNS
Anne Rosser (Cardiff University) Cell therapy for Huntington’s Disease: lessons learned and next steps
Deidre Hoban (Lund University) Development of a novel accelerated α-synuclein rat model of Parkinson’s Disease to assess transplantation of human embryonic stem cell derived dopaminergic neurons
Su-Chu Zhang (Nanyang Technological University Singapore) Stem cell therapy for neurological disorders
Erwan Bezard (University Bordeaux) Cell therapy for Parkinson’s Disease
Azuka Morizane (Kyoto University) HLA matched grafting in primates with induced pluripotent stem cells
Ponsaerts Peter (University Antwerpen) Innate and adaptive immune recognition of autologous and allogeneic cell transplants in the central nervous system of rodents: harmless side effect or therapeutic inflammation?
Romina Aron Badin (CEA Paris) Cell therapy in HD in HLA matched and non-matched NHP recipients
Malú Tansey (Weston Brain Institute US) Neuroinflammation in neurodegenerative disease
Johan Jakobbsson (University Lund) Modelling impaired autophagy in induced neurons derived from patients with Huntington’s Disease
Rebecca Matsas (Pasteur Institute Athens) Exploring p.A53T-alpha synuclein pathology in a human induced pluripotent stem cell-based model
Anselme Perrier (INSERM Paris) Disease modelling of synucleinpathies: propagation of α-synuclein strains with human reconstructed neuronal network
Stefano Pluchino (Cambridge University) Signalling properties of neuronal stem cells and their cargo vesicles
Valentina Fossati (NYSCF New York) Stem cell technology in multiple sclerosis research
Zaal Kokaia (University Lund) Integration and function of transplanted neurons in a rat model of stroke
Christelle Monville (ISTEM Paris) Preclinical validation of a tissue engineered product consisting in RPE derived from human embryonic stem cells disposed on human amniotic membrane of animal models
Datablitz Presentations at NECTAR
Richard Bartlett, England Hydrogel systems to enhance olfactory ensheathing cell delivery after spinal cord injury
Anna Santaella, Netherlands Proteomic profiling of striatal tissue of a rat model of Parkinson’s disease after implantation of collagen-encapsulated mesenchymal stem cells
Rachel Evans, England Alginate hydrogels to encapsulate hiPSC-derived neurons for Parkinson’s Disease
Veronica Alamilla, Ireland Effects of GDF-5-loaded collagen hydrogels after intrastriatal transplantation of ventral mesencephalic cells in a rat model of Parkinson’s disease
Ioanna Syntouka, England Computational analysis of collagen delivery to the striatum
Silvia Cabre, Ireland Potential of an injectable IL-10 rich collagen hydrogel for cell transplantation in Parkinson’s disease
Emma Lane, Wales L-DOPA administration increases GIRK2 expression in hESC-derived dopaminergic grafts
Buket Ucar, Austria Therapeutic Efficacy of GDNF Loaded Collagen Scaffolds in ex vivo organotypic brain slice Parkinson's Disease Models
Ana Garcia, Wales Functional assessment of grafted human embryonic stem cells-derived progenitors in arat model of Huntington’s disease
Torikoshi Sadaharu, Japan Synergistic effects of exercise and cell therapy for Parkinson’s disease
Karolina Pircs, Sweden Activation of autophagy as a treatment strategy in Huntington’s disease
Randall Learish, USA Superior survival, innervation, and functional recovery by hiPSC-derived dopamine neuron progenitor cells in a rat model of Parkinson’s disease
Sara Nolbrant, Sweden Unbiased Gene Expression Analysis Reveals Human Stem Cell-Derived Graft Composition in a Cell Therapy Model of Parkinson’s Disease
Andrew Adler, Sweden Factors affecting synaptic inputs to grafts of hESC-derived neurons in the dopamine-depleted adult rat brain
Ana Lucia Rebelo, Ireland A Method for the Characterisation of N-Glycome from Human Brain Glycoproteins
Daniella Ottosson, Sweden Direct reprogramming of resident glia into parvalbumin interneurons
Vanessa Penna, Australia A novel approach to transcriptionally profile xenografts – a case study examining human pluripotent stem cell-derived neural transplants in the rodent brain
Francesco Gubinelli , France α-syn and LRRK2: a synergetic relationship?
Rosemary Fricker, England Building a functional basal ganglia circuit in vitro to model Parkinson’s and Huntington’s diseases
Sarah McComish, Ireland The effect of inflammatory microglial factors and Apolipoprotein E genotype on astrocytes in a human induced pluripotent stem cell-derived in vitro model of AD
Marcos Herrera, Austria Towards an iPSC-based model for MSA
Friederike von Hövel, Germany Comprehensive evaluation of AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra
Pauline Roost, France Mapping alteration of dopaminergic neurons in a rat model of Parkinson Disease through the comparison of the presynaptic PET tracers
Enrico Bagnoli, Ireland DOPAL and the Olfactory Bulb: a novel platform to mimic prodromal Parkinson’s disease
Cameron Hunt, Australia Utilising hPSC reporter technologies to understand the development and specification of the ventral telencephalon
Shelby Shrigley, Sweden Reprogramming of Adult Human Fibroblasts to Dopaminergic Neurons
Carlos Gantner, Australia Mechanistic underpinnings of cortical lamination in hPSC-derived cortical progenitors
Rachel Hills, Wales Patient derived IPSCs for transplantation in Parkinson’s disease
Alina Langenhagen, Germany Role of fibroblast growth factor 2 on the development of dopaminergic neuronal subpopulations
Marcella Birtele, Sweden Promoting functional maturation of induced human adult neurons
Research Summer School 3 - Entrepreneurship, Exploitation and Commercialization, Glasgow, May 2018
RSS-3 panel image
Alex Muhlholzli Mikota Ltd. Pembroke, UK Start-Ups: The cycle of innovation
Stewart White White Bioconsulting Ltd. Glasgow, UK Commercializing Technology: What is the Value Proposition?
Senthil Alagesan Orbsen Therapeutics, Galway, Ireland ORBCEL™-Purified Allogeneic Stromal Cell Immunotherapies
for immune mediated inflammatory diseases  
Tom Hyland Collagen Solutions Ltd. Freeze drying of collagen materials
Grahame Busby Collagen Solutions Ltd. Biomedical applications of collagen
Vanessa Collingridge Impact Coaching Presentation skills workshop
Mathew Dalby University of Glasgow Nanoscale control of mesenchymal stem cell differentiation
Will Shu University of Strathclyde 3D bioprinting for soft tissue engineering
Cristina González-García University of Glasgow Engineering efficient BMP-2 microenvironments for bone repair
Liz Tanner University of Glasgow Optimization of composite materials: Why and How?
Tilo Kunath University of Edinburgh Human pluripotent stem cells as a model and as a therapy for Parkinson’s disease
Asimina Kazakadi University of Strathclyde Computational haemodynamic research across the extremes of age
Research Summer School 2 - Tissue Engineering, Galway, Ireland, October 2017
Session 1: Developmental Neurobiology
Alpha-synuclein aggregation and toxicity in Parkinson’s disease and other synucleinopathies.
Maria Spillantini, University of Cambridge, UK
Role of microRNAs and neurotrophic factors in the development and maintenance of dopaminergic neurons.
Andrii Domanskyi, University of Helsinki, Finland
In vitro modelling of early human brain development using 2D and organoid systems.
Carlos Villaescusa, Karolinska Institute Stockholm, Sweden
Session 2: Disease – Pathology – Early Markers of PD
Current and future biomarkers for PD
Tom Warner, UCL Institute of Neurology, UK
Differential vulnerability of neurons in Parkinson’s disease - role of cellular stress sensors.
Rosanna Parlato, University Ulm, Germany
The role of astrocytes in alpha-synuclein spreading in Parkinson's disease.
Fabio Cavaliere, University of the Basque Country, Spain
Modeling alpha-synuclein aggregation, propagation and neurotoxicity in rodent brain.
Veerle Baekelandt, University Leuven, Belgium
Session 3: Approaches to Translation – Cell Therapy, Gene Therapy, Biomaterials
A mouse model of motor and non-motor symptoms of Parkinson’s disease: Molecular and behavioural studies.
Gilberto Fisone, Karolinska Institute Stockholm, Sweden
New strategies to develop neuroprotective therapies for Parkinson's disease.
Oliver Bandmann, Sheffield Institute for Translational Neuroscience, UK
Can biomaterials improve cellular reparative approaches for Parkinson's disease?
Eilís Dowd, National University Galway, Ireland
Designing biomaterials systems for the host
Abhay Pandit, National University Galway, Ireland
Session 4: Translational Science – Clinical Trials
Lessons Learned from Clinical Trials in PD.
Ronald Pfeiffer, Oregon Health Science University, USA
Prevention, treatment and management of motor complications and dyskinesia in Parkinson's disease.
Jean-Christophe Corvol, Clinical Research Centre Paris, France
Gene based treatment for PD (OXB-102).
Katie Binley, OxfordBioMedica, Oxford, UK
Clinical Trial Workshop
Martin O’Donnell, HRB Clinical Research Facility, Galway, Ireland
Clinical Trials – Sample Size Calculations
John Newell, National University Ireland Galway
Research Summer School-1 In vitro model systems for neurodegenerative diseases, Denmark, May 2017
Summary Pic
Speaker Affiliation Title
Agnete Kirkeby DanStem, Denmark and Lund University, Sweden Modelling human brain development in vitro with morphogenic microfluidic gradients
Arto Heiskanen Technical University of Denmark (DTU Nanotech) Demonstration of 3D printing of 3D scaffolds and structures
Brian Derby University of Manchester, UK Bioprinting: from Regenerative Medicine to the Organ-on-a-Chip
Carsten Werner Leibniz Institute of Polymer Research, Dresden, Germany Cell-instructive bio-hybdrid hydrogels
Elke Rink National University Ireland Galway, IL Presentation Skills Workshop
Erin Lavik The University of Maryland, Baltimore County (UMBC), USA Building and Repairing the CNS
Ineke Klinge Chair H2020 Advisory Group on Gender, Maastricht University., NL Integration of sex and gender analysis in engineering research: The way to innovation and excellence
Jenny Emnéus Technical University of Denmark (DTU Nanotech) Microfluidic Lab-on-a-Chip systems for cell analysis
Jens Rostrup Nielsen Former R&D director Haldor Topsøe, Founding member of Board of Reviewing Editors of Science How to publish in a high impact paper
Marcel Verbeek Radboud University Medical Center, NL Protein quantification in neurodegeneration
Merab Kokaia Lund University, Sweden Historic perspective of cell-therapy based regenerative medicine
Niels Bent Larsen Technical University of Denmark (DTU Nanotech) 3D stereolithography printing in soft materials for organ-on-a-chip application
Philippe Hantraye Atomic Energy and Alternative Energies Commission, Paris, France Positron emission tomography imaging to study PD
Raimund Strehl NovaHep, Sweden Individualized Tissue Grafts
Una Fitzgerald National University Ireland Galway, IL Ex vivo models of PD